Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany

Clinical trial NCT02450812 · COMPLETED

Trial details

NCT number: NCT02450812
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Neoplasms, Castration-Resistant

Start date: 2015-05-28
Primary completion: 2020-06-30
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.